Implications of Nanoscale Based Drug Delivery Systems in Delivery and Targeting Tubulin Binding Agent, Noscapine in Cancer Cells

被引:16
作者
Chandra, Ramesh [1 ]
Madan, Jitender [1 ]
Singh, Prashant [1 ]
Chandra, Ankush [1 ,3 ]
Kumar, Pradeep [1 ]
Tomar, Vartika [1 ]
Dass, Sujata K. [2 ]
机构
[1] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India
[2] Univ Delhi, VP Chest Inst, Delhi 110007, India
[3] Boston Univ, Boston, MA 02215 USA
关键词
Cancer; noscapine; 9-bromonoscapine; pharmacokinetic; drug delivery; IN-VITRO; NATURAL-PRODUCTS; RATIONAL DESIGN; PROSTATE-CANCER; BREAST-CANCER; NANOPARTICLES; CYTOTOXICITY; APOPTOSIS; TUMORS; ANGIOGENESIS;
D O I
10.2174/138920012803762756
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Noscapine, a tubulin binding anticancer agent undergoing Phase I/II clinical trials, inhibits tumor growth in nude mice bearing human xenografts of breast, lung, ovarian, brain, and prostrate origin. The analogues of noscapine like 9-bromonoscapine (EM011) are 5 to 10-fold more active than parent compound, noscapine. Noscapinoids inhibit the proliferation of cancer cells that are resistant to paclitaxel and epothilone. Noscapine also potentiated the anticancer activity of doxorubicin in a synergistic manner against triple negative breast cancer (TNBC). However, physicochemical and pharmacokinetic (ED50 similar to 300-600 mg/kg bodyweight) limitations of noscapine present hurdle in development of commercial anticancer formulations. Therefore, objectives of the present review are to summarize the chemotherapeutic potential of noscapine and implications of nanoscale based drug delivery systems in enhancing the therapeutic efficacy of noscapine in cancer cells. We have constructed noscapine-enveloped gelatin nanoparticles, NPs and poly (ethylene glycol) grafted gelatin NPs as well as inclusion complex of noscapine in beta-cyclodextrin (beta-CD) and evaluated their physicochemical characteristics. The Fe3O4 NPs were also used to incorporate noscapine in its polymeric nanomatrix system where molecular weight of the polymer governed the encapsulation efficiency of drug. The enhanced noscapine delivery using PAR-targeted optical-MR imaging trackable NPs offer a great potential for image directed targeted delivery of noscapine. Human Serum Albumin NPs (150-300 nm) as efficient noscapine drug delivery systems have also been developed for potential use in breast cancer.
引用
收藏
页码:1476 / 1483
页数:8
相关论文
共 50 条
[1]   Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy [J].
Abdalla, Mohamed O. ;
Karna, Prasanthi ;
Sajja, Hari Krishna ;
Mao, Hui ;
Yates, Clayton ;
Turner, Timothy ;
Aneja, Ritu .
JOURNAL OF CONTROLLED RELEASE, 2011, 149 (03) :314-322
[2]   Synthesis and characterization of noscapine loaded magnetic polymeric nanoparticles [J].
Abdalla, Mohamed O. ;
Aneja, Ritu ;
Dean, Derrick ;
Rangari, Vijay ;
Russell, Albert ;
Jaynes, Jessie ;
Yates, Clayton ;
Turner, Timothy .
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2010, 322 (02) :190-196
[3]  
Alexiou C, 2000, CANCER RES, V60, P6641
[4]   Drug-resistant T-lymphoid tumors undergo apoptosis selectively in response to an antimicrotubule agent, EM011 [J].
Aneja, R ;
Zhou, J ;
Vangapandu, SN ;
Zhou, BF ;
Chandra, R ;
Joshi, HC .
BLOOD, 2006, 107 (06) :2486-2492
[5]   Treatment of hormone-refractory breast cancer: apoptosis and regression of human tumors implanted in mice [J].
Aneja, Ritu ;
Zhou, Jun ;
Zhou, Binfei ;
Chandra, Ramesh ;
Joshi, Harish C. .
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (09) :2366-2377
[6]   Development of a novel nitro-derivative of noscapine for the potential treatment of drug-resistant ovarian cancer and t-cell lymphoma [J].
Aneja, Ritu ;
Vangapandu, Surya N. ;
Lopus, Manu ;
Chandra, Ramesh ;
Panda, Dulal ;
Joshi, Harish C. .
MOLECULAR PHARMACOLOGY, 2006, 69 (06) :1801-1809
[7]   A novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic checkpoint activation in human prostate cancer cells [J].
Aneja, Ritu ;
Miyagi, Tohru ;
Karna, Prasanthi ;
Ezell, Tucker ;
Shukla, Deep ;
Gupta, Meenakshi Vij ;
Yates, Clayton ;
Chinni, Sreenivasa R. ;
Zhau, Haiyen ;
Chung, Leland W. K. ;
Joshi, Harish C. .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (09) :1668-1678
[8]   Nanomaterials: Applications in Cancer Imaging and Therapy [J].
Barreto, Jose A. ;
O'Malley, William ;
Kubeil, Manja ;
Graham, Bim ;
Stephan, Holger ;
Spiccia, Leone .
ADVANCED MATERIALS, 2011, 23 (12) :H18-H40
[9]   Natural products to drugs: natural product-derived compounds in clinical trials [J].
Butler, Mark S. .
NATURAL PRODUCT REPORTS, 2008, 25 (03) :475-516
[10]   Tubulin: A Target for Antineoplastic Drugs into the Cancer Cells but also in the Peripheral Nervous System [J].
Canta, Annalisa ;
Chiorazzi, Alessia ;
Cavaletti, Guido .
CURRENT MEDICINAL CHEMISTRY, 2009, 16 (11) :1315-1324